| 000 | 01732 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516180601.0 | ||
| 264 | 0 | _c20141121 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.4161/cc.26953 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAird, Katherine M | |
| 245 | 0 | 0 |
_aIdentification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _c2014 |
||
| 300 |
_a199-207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aCarcinoma, Ovarian Epithelial |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCellular Senescence |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aEpithelium _xenzymology |
| 650 | 0 | 4 |
_aFallopian Tubes _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKi-67 Antigen _xmetabolism |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xenzymology |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aOvary _xenzymology |
| 650 | 0 | 4 |
_aRibonucleoside Diphosphate Reductase _xgenetics |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aLi, Hua | |
| 700 | 1 | _aXin, Frances | |
| 700 | 1 | _aKonstantinopoulos, Panagiotis A | |
| 700 | 1 | _aZhang, Rugang | |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 13 _gno. 2 _gp. 199-207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cc.26953 _zAvailable from publisher's website |
| 999 |
_c23239965 _d23239965 |
||